Menu
Search
|

Menu

Close
X

AquaBounty Technologies Inc AQB.OQ (NASDAQ Stock Exchange Capital Market)

2.49 USD
+0.00 (+0.00%)
As of Feb 15
chart
Previous Close 2.49
Open 2.36
Volume 5,151
3m Avg Volume 6,744
Today’s High 2.50
Today’s Low 2.36
52 Week High 4.30
52 Week Low 1.55
Shares Outstanding (mil) 15.10
Market Capitalization (mil) 37.75
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
2.00 Mean rating from 1 analysts

KEY STATS

Revenue (mm, USD)
FY18
0
FY17
0
FY16
0
EPS (USD)
FY18
-0.635
FY17
-1.290
FY16
-2.035
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
35.99
Price to Sales (TTM)
vs sector
484.31
10.11
Price to Book (MRQ)
vs sector
1.49
4.60
Price to Cash Flow (TTM)
vs sector
--
26.60
Total Debt to Equity (MRQ)
vs sector
14.08
16.95
LT Debt to Equity (MRQ)
vs sector
13.80
13.45
Return on Investment (TTM)
vs sector
-44.13
12.72
Return on Equity (TTM)
vs sector
-50.45
13.73

EXECUTIVE LEADERSHIP

Richard Clothier
Non-Executive Independent Chairman of the Board, Since 2006
Salary: --
Bonus: --
Sylvia Wulf
President, Chief Executive Officer, Executive Director, Since 2019
Salary: --
Bonus: --
David Frank
Chief Financial Officer, Treasurer, Since 2015
Salary: $273,833.00
Bonus: --
Christopher Martin
General Counsel, Corporate Secretary, Since 2015
Salary: --
Bonus: --
Ronald Stotish
Executive Director, Since 2019
Salary: $363,090.00
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Biotechnology & Medical Research
Address:

2 Clock Tower Pl Ste 395
MAYNARD   MA   01754-2539

Phone: +1978.6486000

AquaBounty Technologies, Inc. is a biotechnology company engaged in research, development and commercialization of the commercial viability of a group of proteins, antifreeze proteins (AFPs). The Company focuses on the managing aquaculture productivity. It offers AquAdvantage Salmon (AAS), which can be grown in contained, land-based facilities. It offers AquAdvantage Salmon for land-based facilities that can be built closer to consumers to manage the need for air freight shipping and transportation. The Company's subsidiaries include AquaBounty Canada, Inc., which operates a commercial biotechnology laboratory that conducts research and development programs related to the Company's technologies; AquaBounty Panama, S. de R.L.; AquaBounty Farms, Inc., and AquaBounty Brasil Participacoes Ltda., which conducts commercial trials of the Company's AquAdvantage Salmon.

SPONSORED STORIES